DIA 2013 49th Annual Meeting
Click here to go to the previous page
The Science of Compliance
Track
:
Track 10: Public Policy/ Health Care Compliance/ Law
Program Code:
352
Date:
Wednesday, June 26, 2013
Time:
1:45 PM to 3:15 PM
EST
Location:
154
CHAIR
:
Patrick C. O'Brien, JD,PharmD (SCHNON), Vice President, Chief Legal Officer, Shire Regenerative Medicine, Inc., United States
SPEAKER
(S):
Patrick C. O'Brien, JD,PharmD (SPKNON), Vice President, Chief Legal Officer, Shire Regenerative Medicine, Inc., United States
Francesca Gino, PhD (SPKSUP), Associate Professor, Negotiation, Organization, and Markets Unit, Harvard University Business School, United States Mary Patrice Brown, JD (SPKNON), Partner, White Collar Defense and Corporate Investigations Practice, O'Melveny & Myers LLP, United States
Description
This forum will discuss how we should be implementing compliance controls in our industry and discuss Codes of Conduct, and the fact that every corporate integrity agreement negotiated between a pharmaceutical or device company and the Office of Inspector General lays out requirements in a way that is probably less likely to be effective than could be.
This session is a part of:
This session is a part of: